Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] - Global Forecast to 2018

News provided by

Nov 20, 2013, 12:09 ET

NEW YORK, Nov. 20, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] – Global Forecast to 2018

http://www.reportlinker.com/p01887614/Dialysis-Market-[Hemodialysis---Machine-Dialyzer-Bloodlines-Concentrates-Services-Peritoneal-Dialysis---Cycler-Catheter-Dialysate-CCPD-CAPD-IPD-End-Users---Hospital-Independent-Dialysis-Center-Home-Dialysis]-–-Global-Forecast-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment

The global dialysis market is broadly categorized into two segments, namely, hemodialysis (products & services) and peritoneal dialysis (products & services). The hemodialysis segment accounts for the larger share of the global market, while the peritoneal dialysis segment is expected to grow at a higher CAGR in the forecast period. The hemodialysis (HD) products and services market includes machines, consumables, and services. The peritoneal dialysis (PD) products and services market includes concentrates/dialysates, cyclers, catheters, transfer sets, accessories, and PD services.

Moreover, the global market has also been classified on the basis of end users into in-center dialysis and home dialysis. The hemodialysis market is further segmented into center use HD and home HD. The peritoneal dialysis market is segmented into continuous cycling peritoneal dialysis (CCPD), continuous ambulatory peritoneal dialysis (CAPD), intermittent PD, and PD Plus therapy. The in-center dialysis end users market includes hospitals and independent dialysis centers; whereas, the home dialysis end users market includes peritoneal dialysis end users and home hemodialysis end users. Based on geography, the market is divided into North America, Asia-Pacific, Europe, and Rest of the World (RoW).

A number of factors such as the growing number of end stage renal disease patients and increasing prevalence of diabetes and hypertension are driving the growth of the dialysis market. In addition, factors such as low preference of patients for kidney transplantation, technological advancements, increase in private investment and venture funding to support the development of new products, and substantial government healthcare expenditure on the treatment of end-stage renal disease are further stimulating the growth of the dialysis products and services market. However, factors such as low awareness about kidney diseases and their treatment modalities (primarily in developing countries), reduction in Medicare reimbursements to dialysis centers, product recalls, and reuse of hemodialysis consumables (such as dialyzers and bloodlines) are restraining the growth of the dialysis market.

In 2013, North America holds the largest share in the global market, followed by Asia-Pacific, Europe, and RoW (Rest of the World). The Asia-Pacific region (comprising Japan, China, South Korea, India, and Rest of Asia-Pacific) is estimated to grow at the highest CAGR in the forecast period. Factors such as the increasing number of independent dialysis centers, government initiatives to develop dialysis facilities, and increasing awareness about new dialysis treatment modalities are driving the growth of the market in the Asia-Pacific region.

The major players in the market include Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), Gambro AB (Sweden), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), Diaverum Deutschland GmbH (Germany), Medical Components, Inc. (U.S.), Nikkiso Co. Ltd. (Japan), and NxStage Medical, Inc. (U.S.).

Scope of the Report

Global Hemodialysis Market, By Products and Services

In-center Hemodialysis services

Home Hemodialysis Services

Hemodialysis Products

Hemodialysis Machines

Center Use Hemodialysis Machines

Home Use Hemodialysis Machines

Hemodialysis Consumables/supplies

Dialyzers

Hemodialysis Access Products

Hemodialysis Bloodlines

Hemodialysis Concentrates/dialysates

Others

Global Peritoneal Dialysis Market, By Products and Services

Peritoneal Dialysis Concentrates/dialysates

Peritoneal Dialysis Machines

Peritoneal Dialysis Catheters

Peritoneal Dialysis Transfer Sets

Other

Peritoneal Dialysis Services

Global Dialysis Market, By Category

Center Use Hemodialysis

Home Hemodialysis

Peritoneal Dialysis

Continuous Cycling Peritoneal Dialysis (CCPD)

Continuous Ambulatory Peritoneal Dialysis (CAPD)

Intermittent PD (IPD)

PD Plus Therapy

Global Dialysis Market, By End Users

Hospitals

Independent Dialysis Centers

Home Dialysis

Peritoneal Dialysis

Home Hemodialysis

Global Dialysis Market, by Geography

North America

Asia-Pacific

Europe

RoW (Rest of the World)

The global market has been segmented into two broad segments, namely, hemodialysis (HD) and peritoneal dialysis (PD). The hemodialysis segment is further categorized into HD products and HD services. The peritoneal dialysis segment is categorized into PD products and PD services. Furthermore, this report describes the HD and PD markets based on category. In this segment, the hemodialysis market includes center use hemodialysis and home hemodialysis. The peritoneal dialysis market is categorized into continuous cycling peritoneal dialysis (CCPD), continuous ambulatory peritoneal dialysis (CAPD), intermittent peritoneal dialysis (IPD), and PD Plus therapy. The CCPD segment holds the largest share of the peritoneal dialysis market in 2013 and is poised to grow at a CAGR of 8.2% in the forecast period. Based on the end users, the global market is segmented into in-center dialysis and home dialysis.

Source: Annual Reports, SEC Filings, Press Releases, Investor Presentations, American Journal of Kidney Diseases, Journal of Nephrology, Kidney Dialysis Foundation, Oxford Journals, International Diabetes Federation, International Society of Hypertension, International Society on Hypertension in Blacks, Peritoneal Dialysis International, American Diabetes Association, American Society of Hypertension, United States Renal Data System, Healthcare Europa, U.K. Renal Registry Report, Kidney Health Australia, Public Health Intelligence New Zealand, Expert Interviews, and MarketsandMarkets Analysis

A number of factors such as the increasing number of ESRD patients and the rising prevalence of diabetes and hypertension are driving the growth of the global market. Furthermore, growth in the number of dialysis facilities in developed as well as developing economies, growth in aging population, and increasing private investments and venture funding to support new product development are some of the other factors that are propelling the growth of the dialysis products and services market. In addition, increasing adoption of new treatment modalities such as home hemodialysis and nocturnal dialysis is further fuelling the growth of this market.

However, a few pivotal factors such as the reduction in Medicare reimbursements to dialysis centers, low awareness about kidney diseases and their treatment modalities, product recalls, reuse of hemodialysis supplies, and poor reimbursement scenario in developing countries are hindering the growth of this market. Moreover, high competition among market players and low cost of kidney transplantation are the foremost challenges faced by industry players.

The global market is dominated by North America, followed by Asia-Pacific, Europe, and Rest of the World (RoW). North America will continue to dominate the market in the forecast period, followed by Asia-Pacific. However, the Asia-Pacific region is expected to grow at the highest CAGR of ~9.7% from 2013 to 2018. Over the next five years, the growth of the dialysis products and services market in the Asia-Pacific region is likely to be centered at Japan, China, South Korea, and India. A number of factors such as the huge patient population base, increasing number of dialysis centres, improving reimbursement and insurance scenario, and increasing government initiatives to develop dialysis facilities are driving the growth of the market in the Asia-Pacific region.

Partnerships, agreements, collaborations, and joint ventures are the key strategies followed by leading market players, to ensure their growth in the market. The introduction of bundle reimbursement system has further increased the number of collaborative partnerships among market players. Mergers and acquisitions, expansions, and new product launch are some of the other growth strategies adopted by industry players in the global market.

The global products and services market is dominated by Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), Gambro AB (Sweden), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), Diaverum Deutschland GmbH (Germany), Medical Components, Inc. (U.S.), Covidien (Ireland), and NxStage Medical, Inc. (U.S.)

1 INTRODUCTION 26

1.2 REPORT DESCRIPTION 26

1.3 MARKETS COVERED 28

1.4 STAKEHOLDERS 29

1.5 MARKET SCOPE 30

1.6 RESEARCH METHODOLOGY 30

1.6.1 MARKET SIZE ESTIMATION 32

1.6.2 MARKET CRACKDOWN & DATA TRIANGULATION 34

1.6.3 MARKET SHARE ESTIMATION 35

1.6.4 KEY DATA POINTS FROM SECONDARY SOURCES 35

1.6.5 KEY DATA POINTS FROM PRIMARY SOURCES 35

1.6.6 ASSUMPTIONS 36

2 EXECUTIVE SUMMARY 37

3 MARKET OVERVIEW 41

3.1 INTRODUCTION 423.2 EVOLUTION 433.3 MARKET SEGMENTATION 453.3.1 HEMODIALYSIS MARKET BY PRODUCTS & SERVICES 463.3.2 PERITONEAL DIALYSIS MARKET BY PRODUCTS & SERVICES 473.3.3 DIALYSIS MARKET BY CATEGORY 483.3.4 DIALYSIS MARKET BY END USERS 493.4 MARKET DYNAMICS 503.4.1 MARKET DRIVERS 513.4.1.1 Growing ESRD Patient Population 513.4.1.2 Growing use of Dialysis for the Treatment of ESRD Patients 523.4.1.3 Increasing Prevalence of Diabetes and Hypertension 523.4.1.4 Growth in Aging Population 523.4.1.5 Low Preference of Patients for Kidney Transplantation 533.4.1.6 Private Investment and Venture Funding to Support Development of New Products 533.4.1.7 Substantial Healthcare Expenditure on the Treatment of End-stage Renal Disease 543.4.1.8 Technological Advancements 543.4.1.9 Increasing Trend of Self Medication 543.4.1.10 Improving Patient Compliance 553.4.2 RESTRAINTS 553.4.2.1 Reduction in Medicare Reimbursements to Dialysis Centers 553.4.2.2 Low Awareness About Kidney Diseases and their Treatment Modalities 563.4.2.3 Associated Risks and After-effects of Dialysis Treatment 563.4.2.4 Product Recalls 563.4.2.5 Reuse of Hemodialysis Supplies 573.4.2.6 Poor reimbursement Scenario in Developing Countries 573.4.3 OPPORTUNITIES 583.4.3.1 Emerging Markets (India, China, and Brazil) 583.4.3.2 Evolution of New Dialysis Modalities 583.4.3.2.1 Home hemodialysis 593.4.3.2.2 Nocturnal dialysis 593.4.3.3 Increasing Number of Dialysis Centers 593.4.4 CHALLENGES 603.4.4.1 Low cost of kidney transplantation 603.4.4.2 Sustainability of Players in the Highly Competitive Market 613.4.5 BURNING ISSUES 623.4.5.1 Reduction in the Reimbursement for Dialysis in the U.S. 623.4.5.2 Introduction of the "Bundled" Dialysis Prospective Payment System (PPS) 623.4.6 WINNING IMPERATIVES 633.4.6.1 Strategy of Diversification of Product Portfolio 633.4.6.2 Strategy of Geographic Expansion in Emerging Markets 643.4.6.3 Partnerships between Dialysis Equipment Manufacturers and Pharmaceutical/Disposable Devices Companies 65

4 INDUSTRY ANALYSIS 67

4.1 INTRODUCTION 674.2 SUPPLY CHAIN ANALYSIS 684.3 PRICING AND COST ANALYSIS 714.4 INDUSTRY TRENDS ANALYSIS 724.4.1 CONSOLIDATION OF DIALYSIS SERVICES MARKET 724.4.2 ONGOING PARTNERSHIPS AMONG DIALYSIS PRODUCTS AND SERVICES PROVIDERS 724.4.3 INCREASING ADOPTION OF PERITONEAL DIALYSIS BY ESRD PATIENTS 734.4.4 ONGOING ROBUST PRIVATE EQUITY ACTIVITY 734.5 PORTER'S FIVE FORCES ANALYSIS 744.5.1 INTENSITY OF COMPETITIVE RIVALRY 754.5.2 BARGAINING POWER OF BUYERS 764.5.3 BARGAINING POWER OF SUPPLIERS 774.5.4 THREAT OF SUBSTITUTES 774.5.5 THREAT OF NEW ENTRANTS 78

5 GLOBAL HEMODIALYSIS MARKET, BY PRODUCTS AND SERVICES 80

5.1 INTRODUCTION 815.2 HEMODIALYSIS PRODUCTS MARKET 835.2.1 HEMODIALYSIS MACHINES MARKET 905.2.1.1 Center Use Hemodialysis Machines Market 935.2.1.2 Home Use Hemodialysis Machines Market 955.2.2 HEMODIALYSIS CONSUMABLES/SUPPLIES MARKET 985.2.2.1 Dialyzers Market 1015.2.2.2 Hemodialysis Access Products Market 1035.2.2.3 Bloodlines Market 1045.2.2.4 Hemodialysis Concentrates/Dialysates Market 1065.2.2.5 Others 1075.3 HEMODIALYSIS SERVICES MARKET 1095.3.1 IN-CENTER HEMODIALYSIS SERVICES MARKET 1155.3.2 HOME HEMODIALYSIS SERVICES MARKET 118

6 GLOBAL PERITONEAL DIALYSIS MARKET, BY PRODUCTS AND SERVICES 120

6.1 INTRODUCTION 1216.2 PERITONEAL DIALYSIS PRODUCTS MARKET 1236.2.1 PERITONEAL DIALYSIS CONCENTRATE/DIALYSATE MARKET 1296.2.2 PERITONEAL DIALYSIS MACHINES MARKET 1306.2.3 PERITONEAL DIALYSIS CATHETERS MARKET 1326.2.4 PERITONEAL DIALYSIS TRANSFER SETS MARKET 1336.2.5 OTHERS 1346.3 PERITONEAL DIALYSIS SERVICES MARKET 136

7 GLOBAL DIALYSIS MARKET, BY CATEGORY 142

7.1 INTRODUCTION 1437.2 HEMODIALYSIS MARKET 1447.2.1 CENTER USE HEMODIALYSIS MARKET 1507.2.2 HOME HEMODIALYSIS MARKET 1527.3 PERITONEAL DIALYSIS MARKET 1547.3.1 CONTINUOUS CYCLING PERITONEAL DIALYSIS (CCPD) MARKET 1617.3.2 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD) MARKET 1637.3.3 INTERMITTENT PERITONEAL DIALYSIS (IPD) MARKET 1647.3.4 PD PLUS THERAPY MARKET 166

8 GLOBAL DIALYSIS MARKET, BY END USERS 168

8.1 INTRODUCTION 1698.2 IN-CENTER DIALYSIS END USERS MARKET 1708.2.1 HOSPITAL DIALYSIS MARKET 1768.2.2 INDEPENDENT DIALYSIS CENTERS MARKET 1778.3 HOME DIALYSIS END USERS MARKET 1798.3.1 PERITONEAL DIALYSIS END USERS MARKET 1858.3.2 HOME HEMODIALYSIS END USERS MARKET 186

9 GLOBAL DIALYSIS MARKET, BY GEOGRAPHY 188

9.1 INTRODUCTION 1899.1.1 DIALYSIS MARKET: GEOGRAPHIC ANALYSIS 1899.2 NORTH AMERICA 1909.2.1 U.S. 1959.2.2 CANADA 1999.3 ASIA-PACIFIC 2029.3.1 JAPAN 2079.3.2 CHINA 2109.3.3 SOUTH KOREA 2139.3.4 INDIA 2169.3.5 REST OF ASIA-PACIFIC 2199.4 EUROPE 2239.4.1 GERMANY 2289.4.2 FRANCE 2319.4.3 ITALY 2349.4.4 U.K. 2379.4.5 REST OF EUROPE 2409.5 REST OF THE WORLD (ROW) 2449.5.1 LATIN AMERICA 2489.5.2 MIDDLE EAST 2529.5.3 AFRICA 256

10 COMPETITIVE LANDSCAPE 260

10.1 OVERVIEW 26010.2 KEY MARKET PLAYERS 26010.3 MARKET SHARE ANALYSIS, BY SEGMENT ANDKEY PLAYERS 26210.3.1 KEY PLAYERS IN THE DIALYSIS PRODUCTS MARKET 26210.3.2 DIALYSIS SERVICES MARKET 26310.3.3 HEMODIALYSIS PRODUCTS MARKET 26510.3.4 PERITONEAL DIALYSIS PRODUCTS MARKET 26710.4 COMPETITIVE SITUATION AND TRENDS 26810.4.1 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES 26910.4.2 MERGERS AND ACQUISITION 27610.4.3 EXPANSION 28110.4.4 NEW PRODUCT LAUNCH 28510.4.5 OTHER DEVELOPMENTS 287

11 COMPANY PROFILES 292

(Overview, Financials, Products & Services, Strategy, & Developments)*

11.1 ASAHI KASEI MEDICAL CO., LTD. 29211.2 B. BRAUN MELSUNGEN AG 29911.3 BAXTER INTERNATIONAL, INC. 30911.4 BELLCO S.R.L. 31711.5 COVIDIEN, PLC 32011.6 DAVITA HEALTHCARE PARTNERS, INC. 32811.7 DIAVERUM DEUTSCHLAND GMBH 33611.8 FRESENIUS MEDICAL CARE AG & CO. KGAA 34211.9 GAMBRO AB 35411.10 KAWASUMI LABORATORIES, INC. 36011.11 MEDICAL COMPONENTS, INC. 36611.12 MEDIONICS INTERNATIONAL, INC. 37011.13 NIKKISO CO. LTD. 37311.14 NIPRO CORPORATION 37911.15 NXSTAGE MEDICAL, INC. 385*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

LIST OF TABLES

TABLE 1 GLOBAL DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 37TABLE 2 GLOBAL HEMODIALYSIS MARKET, BY PRODUCTS AND SERVICES,2011 – 2018 ($BILLION) 82TABLE 3 GLOBAL HEMODIALYSIS PRODUCTS MARKET, BY TYPE,2011 – 2018 ($BILLION) 84TABLE 4 GLOBAL HEMODIALYSIS PRODUCTS MARKET, BY GEOGRAPHY,2011 – 2018 ($BILLION) 85TABLE 5 NORTH AMERICA: HEMODIALYSIS PRODUCTS MARKET, BY COUNTRY, 2011 – 2018 ($BILLION) 86TABLE 6 ASIA-PACIFIC: HEMODIALYSIS PRODUCTS MARKET, BY COUNTRY,2011 – 2018 ($BILLION) 87TABLE 7 EUROPE: HEMODIALYSIS PRODUCTS MARKET, BY COUNTRY,2011 – 2018 ($BILLION) 88TABLE 8 ROW: HEMODIALYSIS PRODUCTS MARKET, BY REGION,2011 – 2018 ($BILLION) 89TABLE 9 GLOBAL HEMODIALYSIS MACHINES MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 92TABLE 10 GLOBAL HEMODIALYSIS MACHINES MARKET, BY GEOGRAPHY,2011 – 2018 ($BILLION) 93TABLE 11 CENTER-USE HEMODIALYSIS MACHINES MARKET, BY GEOGRAPHY, 2011 – 2018 ($BILLION) 95TABLE 12 HOME USE HEMODIALYSIS MACHINES MARKET, BY GEOGRAPHY,2011 – 2018 ($BILLION) 97TABLE 13 GLOBAL HEMODIALYSIS CONSUMABLES/SUPPLIES MARKET,BY SEGMENT, 2011 – 2018 ($BILLION) 100TABLE 14 GLOBAL HEMODIALYSIS CONSUMABLES/SUPPLIES MARKET,BY GEOGRAPHY, 2011 – 2018 ($BILLION) 101TABLE 15 HEMODIALYSIS DIALYZERS MARKET, BY GEOGRAPHY,2011 – 2018 ($BILLION) 102TABLE 16 HEMODIALYSIS ACCESS PRODUCTS MARKET, BY GEOGRAPHY,2011 – 2018 ($BILLION) 104TABLE 17 HEMODIALYSIS BLOODLINES MARKET, BY GEOGRAPHY,2011 – 2018 ($BILLION) 105TABLE 18 HEMODIALYSIS CONCENTRATES/DIALYSATES MARKET,BY GEOGRAPHY, 2011 – 2018 ($BILLION) 107TABLE 19 OTHER HEMODIALYSIS CONSUMABLES MARKET, BY GEOGRAPHY,2011 – 2018 ($BILLION) 108TABLE 20 GLOBAL HEMODIALYSIS SERVICES MARKET, BY TYPE,2011 – 2018 ($BILLION) 110TABLE 21 GLOBAL HEMODIALYSIS SERVICES MARKET, BY GEOGRAPHY,2011 – 2018 ($BILLION) 111TABLE 22 NORTH AMERICA: HEMODIALYSIS SERVICES MARKET, BY COUNTRY, 2011 – 2018 ($BILLION) 112TABLE 23 ASIA-PACIFIC: HEMODIALYSIS SERVICES MARKET, BY COUNTRY,2011 – 2018 ($BILLION) 113TABLE 24 EUROPE: HEMODIALYSIS SERVICES MARKET, BY COUNTRY,2011 – 2018 ($BILLION) 114TABLE 25 ROW: HEMODIALYSIS SERVICES MARKET, BY REGION,2011 – 2018 ($BILLION) 115TABLE 26 GLOBAL IN-CENTER HEMODIALYSIS SERVICES MARKET,BY GEOGRAPHY, 2011 – 2018 ($BILLION) 117TABLE 27 GLOBAL HOME HEMODIALYSIS SERVICES MARKET, BY GEOGRAPHY, 2011 – 2018 ($BILLION) 119TABLE 28 GLOBAL PERITONEAL DIALYSIS MARKET, BY TYPE,2011 – 2018 ($BILLION) 122TABLE 29 GLOBAL PERITONEAL DIALYSIS PRODUCTS MARKET, BY SEBMENT, 2011 – 2018 ($BILLION) 124TABLE 30 GLOBAL PERITONEAL DIALYSIS PRODUCTS MARKET, BY GEOGRAPHY, 2011 – 2018 ($BILLION) 125TABLE 31 NORTH AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET,BY COUNTRY, 2011 – 2018 ($BILLION) 126TABLE 32 ASIA-PACIFIC: PERITONEAL DIALYSIS PRODUCTS MARKET,BY COUNTRY, 2011 – 2018 ($BILLION) 127TABLE 33 EUROPE: PERITONEAL DIALYSIS PRODUCTS MARKET, BY COUNTRY, 2011 – 2018 ($BILLION) 128TABLE 34 ROW: PERITONEAL DIALYSIS PRODUCTS MARKET, BY REGION,2011 – 2018 ($BILLION) 129TABLE 35 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET,2011 – 2018 ($BILLION) 130TABLE 36 PERITONEAL DIALYSIS MACHINES MARKET, BY GOEGRAPHY,2011 – 2018 ($BILLION) 131TABLE 37 PERITONEAL DIALYSIS CATHETERS MARKET, BY GEOGRAPHTY,2011 – 2018 ($BILLION) 132TABLE 38 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY GEOGRAPHY,2011 – 2018 ($BILLION) 134TABLE 39 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY GEOGRAPHY, 2011 – 2018 ($BILLION) 135TABLE 40 GLOBAL PERITONEAL DIALYSIS SERVICES MARKET, BY GEOGRAPHY, 2011 – 2018 ($BILLION) 137TABLE 41 NORTH AMERICA: PERITONEAL DIALYSIS SERVICES MARKET,BY COUNTRY, 2011 – 2018 ($BILLION) 138TABLE 42 ASIA-PACIFIC: PERITONEAL DIALYSIS SERVICES MARKET,BY COUNTRY, 2011 – 2018 ($BILLION) 139TABLE 43 EUROPE: PERITONEAL DIALYSIS SERVICES MARKET, BY COUNTRY, 2011 – 2018 ($BILLION) 140TABLE 44 ROW: PERITONEAL DIALYSIS SERVICES MARKET, BY REGION,2011 – 2018 ($BILLION) 141TABLE 45 GLOBAL DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 143TABLE 46 GLOBAL HEMODIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 145TABLE 47 GLOBAL HEMODIALYSIS MARKET, BY GEOGRAPHY, 2011 – 2018 ($BILLION) 146TABLE 48 NORTH AMERICA: HEMODIALYSIS MARKET, BY COUNTRY,2011 – 2018 ($BILLION) 147TABLE 49 ASIA-PACIFIC: HEMODIALYSIS MARKET, BY COUNTRY,2011 – 2018 ($BILLION) 148TABLE 50 EUROPE: HEMODIALYSIS MARKET, BY COUNTRY,2011 – 2018 ($BILLION) 149TABLE 51 ROW: HEMODIALYSIS MARKET, BY REGION, 2011 – 2018 ($BILLION) 150TABLE 52 CENTER USE HEMODIALYSIS MARKET, BY GEOGRAPHY,2011 – 2018 ($BILLION) 151TABLE 53 HOME HEMODIALYSIS MARKET, BY GEOGRAPHY,2011 – 2018 ($BILLION) 153TABLE 54 GLOBAL PERITONEAL DIALYSIS MARKET, BY TYPE,2011 – 2018 ($BILLION) 156TABLE 55 GLOBAL PERITONEAL DIALYSIS MARKET, BY GEOGRAPHY,2011 – 2018 ($BILLION) 157TABLE 56 NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY COUNTRY,2011 – 2018 ($BILLION) 158TABLE 57 ASIA-PACIFIC: PERITONEAL DIALYSIS MARKET, BY COUNTRY,2011 – 2018 ($BILLION) 159TABLE 58 EUROPE: PERITONEAL DIALYSIS MARKET, BY COUNTRY,2011 – 2018 ($BILLION) 160TABLE 59 ROW: PERITONEAL DIALYSIS MARKET, BY REGION,2011 – 2018 ($BILLION) 161TABLE 60 CONTINUOUS CYCLING PERITONEAL DIALYSIS (CCPD) MARKET,BY GEOGRAPHY, 2011 – 2018 ($BILLION) 162TABLE 61 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD) MARKET,BY GEOGRAPHY, 2011 – 2018 ($BILLION) 164TABLE 62 INTERMITTENT PERITONEAL DIALYSIS (IPD) MARKET, BY GEOGRAPHY, 2011 – 2018 ($BILLION) 165TABLE 63 PD PLUS THERAPY MARKET, BY GEOGRAPHY, 2011 – 2018 ($BILLION) 167TABLE 64 GLOBAL DIALYSIS END USERS MARKET, BY TYPE,2011 – 2018 ($BILLION) 169TABLE 65 GLOBAL IN-CENTER DIALYSIS END USERS MARKET, BY TYPE,2011 – 2018 ($BILLION) 171TABLE 66 GLOBAL IN-CENTER DIALYSIS END USERS MARKET, BY GEOGRAPHY, 2011 – 2018 ($BILLION) 172TABLE 67 NORTH AMERICA: IN-CENTER DIALYSIS END USERS MARKET,BY COUNTRY, 2011 – 2018 ($BILLION) 173TABLE 68 ASIA-PACIFIC: IN-CENTER DIALYSIS END USERS MARKET,BY COUNTRY, 2011 – 2018 ($BILLION) 174TABLE 69 EUROPE: IN-CENTER DIALYSIS END USERS MARKET, BY COUNTRY, 2011 – 2018 ($BILLION) 175TABLE 70 ROW: IN-CENTER DIALYSIS END USERS MARKET, BY REGION,2011 – 2018 ($BILLION) 176TABLE 71 GLOBAL HOSPITAL DIALYSIS MARKET, BY GEOGRAPHY,2011 – 2018 ($BILLION) 177TABLE 72 GLOBAL INDEPENDENT DIALYSIS CENTERS MARKET, BY GEOGRAPHY, 2011 – 2018 ($BILLION) 178TABLE 73 GLOBAL HOME DIALYSIS END USERS MARKET, BY TYPE,2011 – 2018 ($BILLION) 180TABLE 74 GLOBAL HOME DIALYSIS END USERS MARKET, BY GEOGRAPHY,2011 – 2018 ($BILLION) 181TABLE 75 NORTH AMERICA: HOME DIALYSIS END USERS MARKET, BY COUNTRY, 2011 – 2018 ($BILLION) 182TABLE 76 ASIA-PACIFIC: HOME DIALYSIS END USERS MARKET, BY COUNTRY, 2011 – 2018 ($BILLION) 183TABLE 77 EUROPE: HOME DIALYSIS END USERS MARKET, BY COUNTRY,2011 – 2018 ($BILLION) 184TABLE 78 ROW: HOME DIALYSIS END USERS MARKET, BY REGION,2011 – 2018 ($BILLION) 185TABLE 79 GLOBAL PERITONEAL DIALYSIS END USERS MARKET, BY GEOGRAPHY, 2011 – 2018 ($BILLION) 186TABLE 80 GLOBAL HOME HEMODIALYSIS END USERS MARKET, BY GEOGRAPHY, 2011 – 2018 ($BILLION) 187TABLE 81 GLOBAL DIALYSIS MARKET: BY GEOGRAPHY, 2011 – 2018 ($BILLION) 190TABLE 82 NORTH AMERICA: DIALYSIS MARKET, BY COUNTRY,2011 – 2018 ($BILLION) 192TABLE 83 NORTH AMERICA: DIALYSIS MARKET, BY TYPE, 2011 – 2018 193TABLE 84 NORTH AMERICA: HEMODIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 194TABLE 85 NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 195TABLE 86 U.S.: DIALYSIS MARKET, BY TYPE, 2011 – 2018 197TABLE 87 U.S.: HEMODIALYSIS MARKET, BY SEGMENT, 2011 – 2018 ($BILLION) 198TABLE 88 U.S.: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 199TABLE 89 CANADA: DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 200TABLE 90 CANADA: HEMODIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 201TABLE 91 CANADA: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 202TABLE 92 ASIA-PACIFIC: DIALYSIS MARKET, BY COUNTRY,2011 – 2018 ($BILLION) 204TABLE 93 ASIA-PACIFIC: DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 205TABLE 94 ASIA-PACIFIC: HEMODIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 206TABLE 95 ASIA-PACIFIC: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 207TABLE 96 JAPAN: DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 208TABLE 97 JAPAN: HEMODIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 209TABLE 98 JAPAN: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 210TABLE 99 CHINA: DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 212TABLE 100 CHINA: HEMODIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 212TABLE 101 CHINA: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 213TABLE 102 SOUTH KOREA: DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 214TABLE 103 SOUTH KOREA: HEMODIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 215TABLE 104 SOUTH KOREA: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 216TABLE 105 INDIA: DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 218TABLE 106 INDIA: HEMODIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 218TABLE 107 INDIA: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 219TABLE 108 REST OF ASIA-PACIFIC: DIALYSIS MARKET, BY TYPE,2011 – 2018 ($BILLION) 221TABLE 109 REST OF ASIA-PACIFIC: HEMODIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 222TABLE 110 REST OF ASIA-PACIFIC: PERITONEAL DIALYSIS MARKET, BY SEGMENT, 2011 – 2018 ($BILLION) 223TABLE 111 EUROPE: DIALYSIS MARKET, BY COUNTRY, 2011 – 2018 ($BILLION) 225TABLE 112 EUROPE: DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 226TABLE 113 EUROPE: HEMODIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 227TABLE 114 EUROPE: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 228TABLE 115 GERMANY: DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 229TABLE 116 GERMANY: HEMODIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 230TABLE 117 GERMANY: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 231TABLE 118 FRANCE: DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 232TABLE 119 FRANCE: HEMODIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 233TABLE 120 FRANCE: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 234TABLE 121 ITALY: DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 235TABLE 122 ITALY: HEMODIALYSIS MARKET, BY SEGMENT, 2011 – 2018 ($BILLION) 236TABLE 123 ITALY: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 237TABLE 124 U.K.: DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 238TABLE 125 U.K.: HEMODIALYSIS MARKET, BY SEGMENT, 2011 – 2018 ($BILLION) 239TABLE 126 U.K.: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 240TABLE 127 REST OF EUROPE: DIALYSIS MARKET, BY TYPE,2011 – 2018 ($BILLION) 242TABLE 128 REST OF EUROPE: HEMODIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 243TABLE 129 REST OF EUROPE: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 244TABLE 130 ROW: DIALYSIS MARKET, BY REGION, 2011 – 2018 ($BILLION) 246TABLE 131 ROW: DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 247TABLE 132 ROW: HEMODIALYSIS MARKET, BY SEGMENT, 2011 – 2018 ($BILLION) 247TABLE 133 ROW: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 248TABLE 134 LATIN AMERICA: DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 250TABLE 135 LATIN AMERICA: HEMODIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 251TABLE 136 LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 252TABLE 137 MIDDLE EAST: DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 254TABLE 138 MIDDLE EAST: HEMODIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 255TABLE 139 MIDDLE EAST: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 256TABLE 140 AFRICA: DIALYSIS MARKET, BY TYPE, 2011 – 2018 ($BILLION) 257TABLE 141 AFRICA: HEMODIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 258TABLE 142 AFRICA: PERITONEAL DIALYSIS MARKET, BY SEGMENT,2011 – 2018 ($BILLION) 259TABLE 143 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES, 2011 – 2013 270TABLE 144 MERGERS AND ACQUISITIONS, 2011 – 2013 276TABLE 145 EXPANSION, 2011 – 2013 281TABLE 146 NEW PRODUCT LAUNCH, 2011 – 2013 285TABLE 147 OTHER DEVELOPMENTS, 2011 – 2013 288

LIST OF FIGURES

FIGURE 1 GLOBAL DIALYSIS MARKET: RESEARCH METHODOLOGY 31FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY 33FIGURE 3 GLOBAL DIALYSIS MARKET, BY SEGMENTS, 2013 38FIGURE 4 GLOBAL DIALYSIS MARKET, BY GEOGRAPHY, 2013 39FIGURE 5 EVOLUTION OF DIALYSIS 43FIGURE 6 DIALYSIS MARKET: OVERALL SEGMENTATION 45FIGURE 7 HEMODIALYSIS MARKET: OVERALL SEGMENTATION 46FIGURE 8 PERITONEAL DIALYSIS MARKET: OVERALL SEGMENTATION 47FIGURE 9 DIALYSIS MARKET, BY CATEGORY 48FIGURE 10 DIALYSIS MARKET, BY END-USERS 49FIGURE 11 MARKET DYNAMICS: GLOBAL DIALYSIS MARKET 51FIGURE 12 DIALYSIS PRODUCTS AND SERVICES: SUPPLY CHAIN 68FIGURE 13 PORTER'S FIVE FORCES ANALYSIS – GLOBAL DIALYSIS MARKET 74FIGURE 14 GLOBAL DIALYSIS MARKET: INTENSITY OF RIVALRY 75FIGURE 15 GLOBAL DIALYSIS MARKET: BARGAINING POWER OF BUYERS 76FIGURE 16 GLOBAL DIALYSIS MARKET: BARGAINING POWER OF SUPPLIERS 77FIGURE 17 GLOBAL DIALYSIS MARKET: THREAT OF SUBSTITUTES 78FIGURE 18 GLOBAL DIALYSIS MARKET: THREAT OF NEW ENTRANTS 79FIGURE 19 HEMODIALYSIS MACHINES MARKET SEGMENTATION, BY TYPE 90FIGURE 20 HEMODIALYSIS MACHINES MARKET, BY TYPE, 2013 VS. 2018 91FIGURE 21 HEMODIALYSIS CONSUMABLES MARKET SEGMENTATION, BY TYPE 98FIGURE 22 HEMODIALYSIS CONSUMABLES MARKET, BY SEGMENT, 2013 VS. 2018 99FIGURE 23 PERITONEAL DIALYSIS PRODUCTS MARKET, BY SEGMENT,2013 VS. 2018 121FIGURE 24 HEMODIALYSIS MARKET, BY TYPE, 2013 VS. 2018 144FIGURE 25 PERITONEAL DIALYSIS MARKET SEGMENTATION, BY TYPE 154FIGURE 26 PERITONEAL DIALYSIS MARKET, BY TYPE, 2013 VS. 2018 155FIGURE 27 IN-CENTER DIALYSIS END USERS MARKET, BY TYPE, 2013 VS. 2018 170FIGURE 28 HOME DIALYSIS END USERS MARKET, BY TYPE, 2013 VS. 2018 179FIGURE 29 NORTH AMERICA: DIALYSIS MARKET, BY COUNTRY, 2013 VS. 2018 191FIGURE 30 ASIA-PACIFIC: DIALYSIS MARKET, BY COUNTRY, 2013 VS. 2018 203FIGURE 31 EUROPE: DIALYSIS MARKET, BY COUNTRY, 2013 VS. 2018 224FIGURE 32 ROW: DIALYSIS MARKET, BY REGION, 2013 VS. 2018 245FIGURE 33 GLOBAL DIALYSIS MARKET SHARE, BY KEY PLAYERS, 2012 261FIGURE 34 GLOBAL DIALYSIS PRODUCTS MARKET SHARE, BY KEY PLAYERS, 2012 262FIGURE 35 GLOBAL HEMODIALYSIS PRODUCTS MARKET SHARE, BY KEY PLAYERS, 2012 265FIGURE 36 GLOBAL PERITONEAL DIALYSIS PRODUCTS MARKET SHARE,BY KEY PLAYERS, 2012 267FIGURE 37 KEY GROWTH STRATEGIES, 2011 – 2013 268FIGURE 38 ASAHI KASEI MEDICAL CO., LTD.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION) 293FIGURE 39 ASAHI KASEI MEDICAL CO., LTD.: BUSINESS REVENUE MIX, 2012 294FIGURE 40 ASAHI KASEI MEDICAL CO., LTD.: GEOGRAPHIC REVENUE MIX, 2012 294FIGURE 41 ASAHI KASEI CORPORATION: MAJOR STRATEGY, 2011 – 2013 296FIGURE 42 B. BRAUN HOLDING GMBH & CO. KG.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION) 300FIGURE 43 B. BRAUN HOLDING GMBH & CO. KG.: BUSINESS REVENUE MIX, 2012 301FIGURE 44 B. BRAUN HOLDING GMBH & CO. KG.: GEOGRAPHIC REVENUE MIX, 2012 302FIGURE 45 B. BRAUN MELSUNGEN AG: MAJOR STRATEGY, 2011 – 2013 306FIGURE 46 BAXTER INTERNATIONAL, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION) 310FIGURE 47 BAXTER INTERNATIONAL, INC.: BUSINESS REVENUE MIX, 2012 311FIGURE 48 BAXTER INTERNATIONAL, INC.: GEOGRAPHIC REVENUE MIX, 2012 311FIGURE 49 BAXTER INTERNATIONA, INC.: MAJOR STRATEGY, 2011 – 2013 313FIGURE 50 COVIDIEN, PLC: TOTAL REVENUE AND R&D EXPENDITURE,2010 – 2012 ($MILLION) 321FIGURE 51 COVIDIEN, PLC: BUSINESS REVENUE MIX, 2012 322FIGURE 52 COVIDIEN, PLC: GEOGRAPHIC REVENUE MIX, 2012 322FIGURE 53 COVIDIEN PLC: MAJOR STRATEGY, 2011 – 2013 325FIGURE 54 DAVITA HEALTHCARE PARTNERS, INC.: TOTAL REVENUE AND OPERATING EXPENDITURE, 2010 – 2012 ($MILLION) 329FIGURE 55 DAVITA HEALTHCARE PARTNERS, INC.: BUSINESS REVENUE MIX, 2012 330FIGURE 56 DAVITA HEALTHCARE PARTNERS, INC.: MAJOR STRATEGY, 2011 – 2013 332FIGURE 57 DIAVERUM DEUTSCHLAND GMBH: MAJOR STRATEGY, 2011 – 2013 338FIGURE 58 FRESENIUS MEDICAL CARE AG & CO. KGAA: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION) 343FIGURE 59 FRESENIUS MEDICAL CARE AG & CO. KGAA: BUSINESS REVENUE MIX, 2012 344FIGURE 60 FRESENIUS MEDICAL CARE AG & CO. KGAA: GEOGRAPHIC REVENUE MIX, 2012 344FIGURE 61 FRESENIUS MEDICAL CARE AG & CO. KGAA: MAJOR STRATEGY,2011 – 2013 348FIGURE 62 GAMBRO AB: TOTAL REVENUE, 2010 – 2012 ($MILLION) 355FIGURE 63 GAMBRO AB: MAJOR STRATEGY, 2011 - 2013 357FIGURE 64 KAWASUMI LABORATORIES, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2011 – 2013 ($MILLION) 361FIGURE 65 KAWASUMI LABORATORIES, INC.: BUSINESS REVENUE MIX, 2013 361FIGURE 66 KAWASUMI LABORATORIES, INC.: GEOGRAPHIC REVENUE MIX, 2013 362FIGURE 67 KAWASUMI LABORATORIES, INC.: MAJOR STRATEGY, 2011 – 2013 364FIGURE 68 NIKKISO CO. LTD.: TOTAL REVENUE AND R&D EXPENDITURE,2011 – 2013 ($MILLION) 374FIGURE 69 NIKKISO CO. LTD.: BUSINESS REVENUE MIX, 2013 375FIGURE 70 NIKKISO CO. LTD.: GEOGRAPHIC REVENUE MIX, 2013 375FIGURE 71 NIKKISO CO. LTD.: MAJOR STRATEGY, 2011 – 2013 377FIGURE 72 NIPRO CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE,2011 – 2013 ($MILLION) 380FIGURE 73 NIPRO CORPORATION: BUSINESS REVENUE MIX, 2013 381FIGURE 74 NIPRO CORPORATION: GEOGRAPHIC REVENUE MIX, 2013 381FIGURE 75 NXSTAGE MEDICAL, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION) 386FIGURE 76 NXSTAGE MEDICAL, INC.: BUSINESS REVENUE MIX, 2012 387FIGURE 77 NXSTAGE MEDICAL, INC.: MAJOR STRATEGY, 2011 – 2013 389

To order this report: Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] – Global Forecast to 2018 http://www.reportlinker.com/p01887614/Dialysis-Market-[Hemodialysis---Machine-Dialyzer-Bloodlines-Concentrates-Services-Peritoneal-Dialysis---Cycler-Catheter-Dialysate-CCPD-CAPD-IPD-End-Users---Hospital-Independent-Dialysis-Center-Home-Dialysis]-–-Global-Forecast-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker